|
|
40
|
|
|
A5213
|
|
|
SURVANTA 25MG/ML INJ (ABB/PHA) BERACTANT
|
|
|
BERACTANT
|
|
|
SURVANTA
|
|
|
8ML VIAL
|
|
|
BQ
|
|
|
1,043.59
|
|
|
1,043.59
|
|
|
25MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
ABB
|
|
|
ABBOTT
|
|
|
PHA
|
|
|
PHARMACY SALES CARIBBEAN
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
4836
|
|
|
PULMONARTY SURFCTANTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
RESPIRATORY TRACT AGENTS
|
|
|
|